Clinical Trial Assessment: Reviewing the design, methodology, and outcomes of ongoing and completed clinical trials to ensure they are robust and scientifically sound.

Efficacy and Safety Analysis: Evaluating the efficacy and safety profiles of drug candidates to determine their therapeutic potential and identify any significant adverse effects or safety concerns.

Unmet Medical Needs: Assessing how well the drug candidates address current unmet medical needs and their potential impact on patient care.

Scientific Validity: Evaluating the scientific basis of the drug candidates, including mechanisms of action, preclinical data, and biomarker development.

Competitive Landscape: Analyzing the competitive environment to understand the positioning of drug candidates relative to existing and emerging therapies.

Development Risks: Identifying potential risks in the development program, such as issues with trial design, patient recruitment, or regulatory challenges, and proposing mitigation strategies.

Cross-Functional Collaboration: Working with other departments, such as regulatory, commercial, and manufacturing teams, to provide clinical insights that inform the overall evaluation process.

Strategic Fit: Assessing how well the drug candidates align with the company’s strategic goals and therapeutic areas of focus.

Future Potential: Estimating the long-term potential of drug candidates, including their likelihood of success in later-stage trials and their market viability.